Trilaciclib 60012 InChi: InChI=1S/C19H16N6O/c20-18(26)15-3-1-14(2-4-15)16-12-23-25-10-7-17(24-19(16)25)22-11-13-5-8-21-9-6-13/h1-10

InChi: InChI=1S/C19H16N6O/c20-18(26)15-3-1-14(2-4-15)16-12-23-25-10-7-17(24-19(16)25)22-11-13-5-8-21-9-6-13/h1-10

9-Difluoro-7-[2-[(1S

GSK0660 is a potent antagonist of PPARβ and PPARδ

At 50 μM MD

4-dihydro-2H-pyran-5-carboxylate

Trilaciclib 60012 InChi: InChI=1S/C19H16N6O/c20-18(26)15-3-1-14(2-4-15)16-12-23-25-10-7-17(24-19(16)25)22-11-13-5-8-21-9-6-13/h1-10Trilaciclib (G1T28, G1T28 1) is a highly potent, selective and reversible cyclin dependent kinase 4 and 6 (CDK4 6) inhibitor. Trilaciclib inhibits CDK4 cyclin D1 and CDK6 cyclin D3 with IC50 of 1 nM and 4 nM, respectively. Product information CAS Number: 1374743 00 6 Molecular Weight: 446. 55 Formula: C24H30N8O Chemical Name: 2' ((5 (4 methylpiperazin 1 yl)pyridin 2 yl)amino) 7',8' dihydro 6'H spiro[cyclohexane 1,9' pyrazino[1',2': 1,5]pyrrolo[2,3